2 Results for "

DNDI-VL-2098

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "DNDI-VL-2098" in MCE Product Catalog:

Cat. No.: HY-W663179
CAS No.: 681492-17-1
Research Areas:  

Infection

DNDI-VL-2098 is an orally active antileishmanial agent. DNDI-VL-2098 exhibits high permeability, in vitro metabolic stability, and selective inhibition of CYP2C19 (IC50=0.47 μM). DNDI-VL-2098 does not affect the activities of other major CYP enzymes (CYP1A2, CYP2C9, CYP2D6 and CYP3A4) at concentrations up to 12.5 μM. It shows favorable pharmacokinetic properties in multiple animal models including mice, hamsters, rats and dogs. DNDI-VL-2098 is characterized by moderate to high plasma protein binding and can be used for the research of visceral leishmaniasis .
loading...
    loading...
Cat. No.: HY-156132
CAS No.: 2097881-13-3
Target:  

Parasite

Research Areas:  

Infection

DNDI-0690 is a potent orally active analogue of DNDI-VL-2098, exhibiting potent activity against cutaneous leishmaniasis (CL). DNDI-0690 shows potent in vitro activity against CL-causing Leishmania species (EC50 = 0.17 μM against visceral leishmaniasis (VL), and < 5 μM against CL-causing species). DNDI-0690 exerts effects in a mouse model of L. major CL. DNDI-0690 can be used for CL research .
loading...
    loading...